Literature DB >> 1575679

Differential pathways (phospholipase C and phospholipase D) of bradykinin-induced biphasic 1,2-diacylglycerol formation in non-transformed and K-ras-transformed NIH-3T3 fibroblasts. Involvement of intracellular Ca2+ oscillations in phosphatidylcholine breakdown.

T Fu1, Y Okano, Y Nozawa.   

Abstract

Bradykinin (BK) induced a biphasic increase in 1,2-diacylglycerol (DAG) in both K-ras-transformed fibroblasts (DT) and the parent NIH-3T3 cells. The first phase was coincident with the increase in Ins(1,4,5)P3 resulting from PtdIns(4,5)P2 hydrolysis, and the second, sustained, phase was derived from phosphatidylcholine (PtdCho) hydrolysis. In NIH-3T3 cells, stimulation by BK induced greater production of choline than phosphocholine in [3H]choline-labelled cells and appreciable phosphatidylethanol (PtdEtOH) formation in [3H]myristic acid-labelled cells, suggesting that PtdCho was hydrolysed mainly by a phospholipase D (PLD) activity. Pretreatment with propranolol, an inhibitor of phosphatidate phosphohydrolase, markedly diminished the second DAG accumulation, supporting the above notion. In DT cells, BK induced predominantly phosphocholine generation and little PtdEtOH formation, indicating that the PtdCho hydrolysis was due to a phospholipase C (PLC) activity. The BK-induced oscillations in intracellular Ca2+ concentration ([Ca2+]i) observed in single DT cells [Fu, Sugimoto, Oki, Murakami, Okano & Nozawa (1991) FEBS Lett. 281, 263-266] were detected as a sustained [Ca2+]i elevation when assayed in a cell suspension. A receptor-operated Ca2+ channel blocker, SK&F 96365, suppressed both the BK-induced phosphocholine generation and the sustained [Ca2+]i elevation in a similar dose-dependent manner. These results thus suggested that oscillations in [Ca2+]i are involved in the activation of PtdCho-specific PLC in DT cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1575679      PMCID: PMC1131040          DOI: 10.1042/bj2830347

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  54 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  p21ras-induced responsiveness of phosphatidylinositol turnover to bradykinin is a receptor number effect.

Authors:  J Downward; J de Gunzburg; R Riehl; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

Review 3.  ras GTPase activating protein: signal transmitter and signal terminator.

Authors:  F McCormick
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

4.  Mutant but not normal p21 ras elevates inositol phospholipid breakdown in two different cell systems.

Authors:  J F Hancock; C J Marshall; I A McKay; S Gardner; M D Houslay; A Hall; M J Wakelam
Journal:  Oncogene       Date:  1988-08       Impact factor: 9.867

5.  Normal p21N-ras couples bombesin and other growth factor receptors to inositol phosphate production.

Authors:  M J Wakelam; S A Davies; M D Houslay; I McKay; C J Marshall; A Hall
Journal:  Nature       Date:  1986 Sep 11-17       Impact factor: 49.962

6.  Phosphatidate accumulation in hormone-treated hepatocytes via a phospholipase D mechanism.

Authors:  S B Bocckino; P F Blackmore; P B Wilson; J H Exton
Journal:  J Biol Chem       Date:  1987-11-05       Impact factor: 5.157

7.  Purification and characterization of membrane-bound phospholipase C specific for phosphoinositides from human platelets.

Authors:  Y Banno; Y Yada; Y Nozawa
Journal:  J Biol Chem       Date:  1988-08-15       Impact factor: 5.157

8.  Phospholipase D activation by the mitogens platelet-derived growth factor and 12-O-tetradecanoylphorbol 13-acetate in NIH-3T3 cells.

Authors:  P Ben-Av; M Liscovitch
Journal:  FEBS Lett       Date:  1989-12-18       Impact factor: 4.124

9.  Kinetic analysis of 1,2-diacylglycerol mass levels in cultured fibroblasts. Comparison of stimulation by alpha-thrombin and epidermal growth factor.

Authors:  T M Wright; L A Rangan; H S Shin; D M Raben
Journal:  J Biol Chem       Date:  1988-07-05       Impact factor: 5.157

10.  Phospholipase D catalyzes phospholipid metabolism in chemotactic peptide-stimulated HL-60 granulocytes.

Authors:  J K Pai; M I Siegel; R W Egan; M M Billah
Journal:  J Biol Chem       Date:  1988-09-05       Impact factor: 5.157

View more
  7 in total

1.  Activation of phospholipase C increases intramembrane electric fields in N1E-115 neuroblastoma cells.

Authors:  Chang Xu; Leslie M Loew
Journal:  Biophys J       Date:  2003-06       Impact factor: 4.033

2.  Potentiated bradykinin-induced increase of 1,2-diacylglycerol generation and phospholipase D activity in human senescent fibroblasts.

Authors:  E Meacci; V Vasta; P Faraoni; M Farnararo; P Bruni
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

3.  Prostaglandin F2 alpha-stimulated phospholipase D activation in osteoblast-like MC3T3-E1 cells: involvement in sustained 1,2-diacylglycerol production.

Authors:  T Sugiyama; T Sakai; Y Nozawa; N Oka
Journal:  Biochem J       Date:  1994-03-01       Impact factor: 3.857

4.  Accumulation of phosphatidylalcohol in cultured cells: use of subcellular fractionation to investigate phospholipase D activity during signal transduction.

Authors:  Y S Edwards; A W Murray
Journal:  Biochem J       Date:  1995-06-01       Impact factor: 3.857

5.  HIF-independent regulation of thioredoxin reductase 1 contributes to the high levels of reactive oxygen species induced by hypoxia.

Authors:  Salvador Naranjo-Suarez; Bradley A Carlson; Petra A Tsuji; Min-Hyuk Yoo; Vadim N Gladyshev; Dolph L Hatfield
Journal:  PLoS One       Date:  2012-02-13       Impact factor: 3.240

6.  Regulation of calreticulin gene expression by calcium.

Authors:  M Waser; N Mesaeli; C Spencer; M Michalak
Journal:  J Cell Biol       Date:  1997-08-11       Impact factor: 10.539

7.  Targeting thioredoxin reductase 1 reduction in cancer cells inhibits self-sufficient growth and DNA replication.

Authors:  Min-Hyuk Yoo; Xue-Ming Xu; Bradley A Carlson; Andrew D Patterson; Vadim N Gladyshev; Dolph L Hatfield
Journal:  PLoS One       Date:  2007-10-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.